Wed, Aug 20, 2014, 4:06 AM EDT - U.S. Markets open in 5 hrs 24 mins

Recent

% | $
Quotes you view appear here for quick access.

Aastrom Biosciences, Inc. Message Board

  • allo.generic allo.generic Mar 27, 2013 4:23 PM Flag

    GERN CTIC AND ASTM WILL DOOM STEM CELL DEVELOPEMENT FOR DECADES.

    More far reaching impact of ASTM's demise besides just ASTM. This will adversely impact all Stem Cell companies from raising capital in the market place than just ASTM.

    This BOD and their handling of this entire fiasco has been putrid.

    I agree with whomever it was that wanted the proxies to vote this BOD out.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The view science has to this sector is it is a paradign shift in human eveloution. Perhaps you can explain your scientific reasoning to such a statement.

      Other than of course the scientific approach to "i got burned"

      There are plenty of worth while and potentially extremely lucrative investment opportunities withing the immuno/Regen stemcell sector.

      The writing was on the wall with this one. Very like AMRN before it's drop (and they got approved) all the signals were there for grounded investors to see the writing on the wall.

      GLTA

 
ASTM
3.75+0.14(+3.88%)Aug 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.